We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$391M
AUM Growth
+$24.9M
Cap. Flow
+$6.5M
Cap. Flow %
1.66%
Top 10 Hldgs %
24.49%
Holding
285
New
24
Increased
110
Reduced
87
Closed
16
Avg Time Held Equity + Options
14 quarters
Top 10 Avg Time Held Equity + Options
10.8 quarters
Top 20 Avg Time Held Equity + Options
12.8 quarters
Avg Time Held Equity only
14 quarters
Top 10 Avg Time Held Equity only
10.8 quarters
Top 20 Avg Time Held Equity only
12.8 quarters

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$3.14M
2
META icon
Meta Platforms (Facebook)
META
+$1.99M
3
NVDA icon
NVIDIA
NVDA
+$1.87M
4
AMZN icon
Amazon
AMZN
+$1.54M
5
GILD icon
Gilead Sciences
GILD
+$1.47M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.37%
2 Technology 20.82%
3 Consumer Discretionary 13.26%
4 Financials 10.08%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
QQQ icon
151
Invesco QQQ Trust
QQQ
$497B
$757K 0.19%
1,549
+6
+0.4% +$2.84K
2022 Q2
9 quarters
RNG icon
152
RingCentral
RNG
$6.57B
$756K 0.19%
23,900
+4,300
+22% +$136K
2021 Q4
11 quarters
URI icon
153
United Rentals
URI
$66B
$752K 0.19%
+929
New +$668K
2024 Q3
0 quarters
RKLB icon
154
Rocket Lab Corp
RKLB
$41.1B
$748K 0.19%
76,825
+13,222
+21% +$80.3K
2022 Q3
8 quarters
ANET icon
155
Arista Networks
ANET
$258B
$740K 0.19%
7,708
+108
+1% +$9.41K
2023 Q1
6 quarters
AMAT icon
156
Applied Materials
AMAT
$368B
$737K 0.19%
+3,650
New +$749K
2024 Q3
0 quarters
NLY icon
157
Annaly Capital Management
NLY
$13.7B
$731K 0.19%
35,300
-450
-1% -$9.01K
2024 Q1
2 quarters
MRK icon
158
Merck
MRK
$350B
$730K 0.19%
+6,426
New +$763K
2024 Q3
0 quarters
IT icon
159
Gartner
IT
$12.4B
$729K 0.19%
1,439
– –
2016 Q4
31 quarters
XLV icon
160
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$727K 0.19%
4,720
-140
-3% -$21.2K
2019 Q1
22 quarters
OXY icon
161
Occidental Petroleum
OXY
$61.6B
$712K 0.18%
13,765
+9,238
+204% +$527K
2024 Q2
1 quarter
GD icon
162
General Dynamics
GD
$89.9B
$695K 0.18%
+2,299
New +$676K
2024 Q3
0 quarters
ZM icon
163
Zoom
ZM
$28.6B
$691K 0.18%
9,910
– –
2020 Q3
16 quarters
COR icon
164
Cencora
COR
$63B
$688K 0.18%
3,058
+182
+6% +$42.3K
2023 Q4
3 quarters
CMCSA icon
165
Comcast
CMCSA
$74.1B
$682K 0.17%
16,320
-277
-2% -$10.9K
2016 Q4
31 quarters
MO icon
166
Altria Group
MO
$119B
$668K 0.17%
12,840
+577
+5% +$29.2K
2017 Q2
29 quarters
FGD icon
167
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.56B
$666K 0.17%
+27,364
New +$641K
2024 Q3
0 quarters
NOC icon
168
Northrop Grumman
NOC
$68.4B
$647K 0.17%
1,225
-41
-3% -$20.1K
2016 Q4
31 quarters
TSN icon
169
Tyson Foods
TSN
$18.9B
$644K 0.16%
10,807
-392
-4% -$23.9K
2020 Q3
16 quarters
HYS icon
170
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.67B
$639K 0.16%
6,692
+2,485
+59% +$233K
2023 Q3
4 quarters
LOW icon
171
Lowe's Companies
LOW
$106B
$637K 0.16%
2,352
+23
+1% +$5.57K
2023 Q2
5 quarters
C icon
172
Citigroup
C
$209B
$612K 0.16%
9,780
+3,574
+58% +$221K
2016 Q4
31 quarters
ROKU icon
173
Roku
ROKU
$22.7B
$611K 0.16%
8,187
-1,650
-17% -$106K
2023 Q3
4 quarters
APA icon
174
APA Corp
APA
$16.8B
$610K 0.16%
24,950
-500
-2% -$14K
2022 Q1
10 quarters
NUVB icon
175
Nuvation Bio
NUVB
$1.66B
$599K 0.15%
261,405
+14,500
+6% +$44.2K
2020 Q4
15 quarters

Similar funds

Intellectus Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Intellectus Partners held 285 positions worth $391M, up 6.8% from $366M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Intellectus Partners's Q3 2024 filing shows 24 new, 110 increased, 87 reduced and 16 closed positions. Its largest new stake was Corcept Therapeutics: 54,859 shares worth $2.54M. The largest sale was KLA, an estimated $3.14M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Intellectus Partners's largest Q3 2024 buy was Corcept Therapeutics: 54,859 shares worth $2.54M.
  • Intellectus Partners added most to Snowflake in Q3 2024, an estimated $1.78M increase.
  • Intellectus Partners's biggest Q3 2024 reduction was KLA, cutting an estimated $3.14M.
  • Intellectus Partners fully exited Biogen in Q3 2024, selling an estimated $1.4M.
  • Intellectus Partners's ten largest holdings make up 24% of its $391M portfolio in Q3 2024.
  • Intellectus Partners opened 24 new positions and closed 16 in Q3 2024.
  • Intellectus Partners's portfolio value rose 6.8% quarter-over-quarter to $391M.

Based on Intellectus Partners's 13F filing for Q3 2024, filed 6 Nov 2024.